02-Feb-2022 - Universität Basel

Safeguarding the cell nucleus

Damage to this biological security system is detrimental to cells, and has been associated with cancer and neurodegenerative diseases

The nucleus is guarded by a highly secure door, the so-called nuclear pore, that controls the transport of substances from the cytoplasm to the cell nucleus and back. A research group at the University of Basel has now shown that different shuttle proteins occupy the nuclear pore to prevent unsolicited leakage of molecules. These proteins form an escape-proof, failsafe mechanism by compensating for one another to fortify the pore.

The nuclear pore is responsible for regulating the transport of proteins from the cytoplasm into the cell nucleus and for ushering RNA out of it. It works like a molecular sieve that controls the entry and exit of cargo-carrying shuttle proteins. The molecular sieve interacts with shuttle proteins, which, like gatekeepers, decide which proteins are allowed to enter and which are not.

Professor Roderick Lim from the Biozentrum of the University of Basel aims to resolve this enigmatic selective transport system. His team, in collaboration with the Swiss Nanoscience Institute, has now examined three prominent shuttle proteins in human cells and uncovered that their crowding at nuclear pores is important for preventing unwanted leakage into and out of the nucleus.

The number of shuttle proteins that occupy the pore depends on their concentrations within the cell. However, when one shuttle protein is reduced, another shuttle protein can take its place to reinforce the pore. The results of this novel compensation mechanism have now been published in the Journal of Cell Biology.

Interchangeable shuttle proteins safeguard the nuclear pore

"It turns out that the shuttle proteins, although they are from the same receptor family, differ in function in terms of the cargo they carry, localization and concentration," says Dr. Joanna Kalita, first author of the study. The shuttle proteins, which act like gatekeepers at the nuclear pore and decide which cargoes are allowed to enter the cell nucleus and which have to be escorted out, reside in the nuclear pore at varying amounts – depending on their respective concentrations.

When the researchers changed the concentration of one of the shuttle proteins, the number of the other two proteins that occupied the nuclear pore also changed. “If the total number of shuttle proteins in the pore gets reduced, the nuclear pore becomes leaky. Thus, cells rely on a mechanism that allows the loss of one shuttle protein to be compensated by the increase of another. That’s how the shuttle proteins safeguard the nuclear pores," says Kalita.

Diseases caused by defective nuclear pores

Damage to this biological security system is detrimental to cells, and has been associated with cancer and neurodegenerative diseases. Viruses that infect cells, such as SARS-CoV-2, can also trap these shuttle proteins away from the nuclear pore to impair its functionality. "This can lead to defects in the nuclear pore and as a consequence, undesirable substances can freely penetrate the nuclear pores and ‘poison’ the nucleus.

Conversely, substances important for the cell nucleus are no longer imported. Clearly, deeper insights into nuclear pore function will be important for understanding the causes and consequences of defective nuclear transport with respect to disease," explains Lim.

Facts, background information, dossiers
  • cell nucleus
  • nuclear pores
  • cytoplasm
More about Universität Basel
  • News

    Good bacteria to tackle depression

    Intestinal flora plays an important role in health – including mental health. Researchers from the University of Basel and the University Psychiatric Clinics Basel (UPK) have shown that probiotics can support the effect of antidepressants and help to alleviate depression. When he was visite ... more

    Making cell therapies gentler and more efficient

    Cell therapies are the new hope when it comes to tackling diseases such as leukemia or multiple sclerosis, but they require an intensive and strenuous course of pretreatment. Researchers from the University of Basel and the University Hospital of Basel have developed an approach to make bot ... more

    Therapy for muscular dystrophy: A new start-up

    Prof. Markus Rüegg and Dr. Judith Reinhard from the Biozentrum of the University of Basel have founded the start-up SEAL Therapeutics AG together with Dr. Thomas Meier, former CEO of Santhera Pharmaceuticals. Their goal is to treat congenital muscular dystrophy using gene therapy and to bri ... more

  • Videos

    Virtual Reality in Medicine: New Opportunities for Diagnostics and Surgical Planning

    Before an operation, surgeons have to obtain the most precise image possible of the anatomical structures of the part of the body undergoing surgery. University of Basel researchers have now developed a technology that uses computed tomography data to generate a three-dimensional image in r ... more

    Nuclear Pores Captured on Film

    Zooming into a nuclear pore complex using a high-speed atomic force microscope reveals the selectivity barrier that filters the traffic of molecules passing between the cytoplasm and nucleus in eukaryotic cells. This is comprised of intrinsically disordered proteins known as FG Nucleoporins ... more